(a) Specifications.
         The drug contains 0.2 percent nitrofurazone and 0.5 percent butacaine sulfate in a water-soluble base.
     
    
        
        (b) Sponsor.
         See No. 054925 in  § 510.600(c) of this chapter.
     
    
        
        (c) Conditions of use—
        
        (1) Indications for use.
         For prevention or treatment of surface bacterial infections of ears, wounds, burns, and cutaneous ulcers of dogs, cats, and horses. 1
     
    
        
            Code of Federal Regulations
        
        
            
            Footnote(s):
            
                
                    1 These conditions are NAS/NRC reviewed and deemed effective. Applications for these uses need not include effectiveness data as specified by § 514.111 of this chapter, but may require bioequivalency and safety information.
            
            
        
    
    
        
        (2) Limitations.
         Apply directly on the lesion with a spatula or first place on a piece of gauze. Use of a bandage is optional. The preparation should remain on the lesion for at least 24 hours. The dressing may be changed several times daily or left on the lesion for a longer period. For use only on dogs, cats, and horses (not for food use). In case of deep or puncture wounds or serious burns, use only as recommended by a veterinarian. If redness, irritation, or swelling persists or increases, discontinue use; consult veterinarian. 1
     
    
        
            Code of Federal Regulations
        
        [49 FR 9417, Mar. 13, 1984, as amended at 71 FR 13542, Mar. 16, 2006]